Welcome to our dedicated page for Concentrix SEC filings (Ticker: CNXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Concentrix Corporation (NASDAQ: CNXC) SEC filings page on Stock Titan provides access to the company’s official disclosures as filed with the U.S. Securities and Exchange Commission. As a Fortune 500 public company, Concentrix uses SEC reports to communicate details about its financial performance, risk factors, capital structure, and significant corporate events.
Among the key filings, investors typically review annual reports on Form 10-K and quarterly reports on Form 10-Q to understand revenue trends, operating income, non-GAAP measures referenced in earnings releases, cash flow, and segment information. Current reports on Form 8-K, such as those furnished for quarterly earnings announcements, give timely updates on results of operations and financial condition, and may include press releases as exhibits.
For those tracking ownership and governance, Forms 3, 4, and 5 (if available) can be used to monitor insider transactions by directors, officers, and significant shareholders. Proxy statements on Schedule 14A, when filed, typically provide information on executive compensation, board structure, and matters submitted to shareholder votes.
On Stock Titan, Concentrix filings are supplemented with AI-powered summaries that explain the main points of lengthy documents in clear language. Real-time updates from the EDGAR system help users see new CNXC filings as they appear, while AI-generated highlights make it easier to identify sections related to non-GAAP metrics, AI and technology investments, and other topics emphasized in the company’s earnings materials. This page is a useful starting point for anyone researching Concentrix’s regulatory history, financial reporting practices, and material disclosures.
Concentrix Corp executive Gibson Craig, EVP of Global Sales and Account Management, reported a disposition of common stock in a Form 4 filing. On February 1, 2026, Craig disposed of 799 shares of Concentrix common stock at $37.35 per share. After this transaction, he directly owned 53,599 shares of Concentrix common stock.
Concentrix Corp executive Jane Fogarty, EVP, Legal, reported a disposition of Concentrix common stock. On 02/01/2026, 563 shares were disposed of at a price of $37.35 per share. Following this transaction, she directly beneficially owned 31,030 shares of Concentrix common stock.
Concentrix Corp President and CEO Christopher A. Caldwell reported buying additional company stock in an open-market transaction. On January 29, 2026, he purchased 1,000 shares of Concentrix common stock at a price of $37.07 per share, coded as a purchase transaction.
Following this trade, Caldwell beneficially owned 362,075 shares of Concentrix common stock, held in direct ownership. This filing reflects an increase in his personal equity stake and aligns his financial interests further with those of other shareholders.
Groupe Bruxelles Lambert and its affiliates amended their Schedule 13D on Concentrix Corporation to update ownership percentages. They report beneficial ownership of 8,773,667 shares of common stock, representing about 14.24% of Concentrix’s outstanding shares, based on 61,597,304 shares outstanding as of January 16, 2026.
The change in percentage ownership results solely from a decrease in Concentrix’s total shares outstanding. The filing also notes potential receipt of 442,759 additional earnout shares if specified share-price conditions are met and reiterates investor rights, including board nomination, lock-up, and registration rights under an existing Investor Rights Agreement.
Concentrix Corp President and CEO Christopher A. Caldwell reported routine equity compensation activity involving company common stock. On January 28, 2026, he acquired 2,855 shares of common stock at $0 per share upon the vesting of restricted stock units granted under the 2020 Stock Incentive Plan and tied to performance metrics over a three-year period ending November 30, 2025.
On the same date, 1,210 shares were withheld at a price of $36.32 per share, a transaction coded as "F," typically reflecting shares surrendered to cover tax obligations. After these transactions, Caldwell directly owned 361,075 shares of Concentrix common stock.
Concentrix Corp Chief Financial Officer Valentine Andre S reported stock transactions dated January 28, 2026. The filing shows an acquisition of 436 shares of common stock at $0 per share, tied to restricted stock units that vested under the 2020 Stock Incentive Plan after performance was measured over a three-year period ending November 30, 2025.
The report also shows a disposition of 130 shares of common stock at $36.32 per share on the same date. After these transactions, the executive directly held 87,430 shares of Concentrix common stock.
Concentrix Corp EVP Cormac J. Twomey reported routine equity compensation activity. On January 28, 2026, he acquired 491 shares of common stock at $0 upon vesting of performance-based restricted stock units granted under the 2020 Stock Incentive Plan. On the same date, 231 shares were disposed of at $36.32 per share, reflecting shares withheld to cover taxes. After these transactions, he directly owned 58,434 Concentrix common shares.
Concentrix Corp executive Jane Fogarty reported routine equity compensation activity. On January 28, 2026, she acquired 220 shares of common stock at $0 per share upon vesting of performance-based restricted stock units granted under the 2020 Stock Incentive Plan. On the same date, 79 shares were disposed of at $36.32 per share, typically reflecting shares withheld to cover taxes, leaving her with 31,593 shares of Concentrix common stock held directly.
Concentrix Corp President and CEO Christopher A. Caldwell reported a disposition of company common stock. On January 27, 2026, a transaction coded "F" involved 2,591 shares of Concentrix common stock at a price of $41.61 per share. Following this transaction, Caldwell beneficially owned 359,430 shares of Concentrix common stock in direct ownership.
Concentrix Corp executive Cormac J. Twomey reported a small share disposition under a Form 4 filing. On 01/27/2026, Twomey, EVP, Global Ops & Delivery, recorded a transaction in Common Stock coded "F" involving 495 shares at $41.61 per share. Following this transaction, he directly beneficially owned 58,174 shares of Concentrix common stock.